Christina van der Linden

Dr. Christina van der Linden

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 December 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
JBJuan Carlos Baldermann
Juan Carlos Baldermann
JPJan Niklas Petry-Schmelzer
Jan Niklas Petry-Schmelzer
TSThomas Schüller
Thomas Schüller
LMLin Mahfoud
Lin Mahfoud
GBGregor A. Brandt
Gregor A. Brandt
MBMichael T. Barbe
Michael T. Barbe
Gilles de la Tourette Syndrome (GTS) is a chronic tic disorder, characterized by unwanted motor actions and vocalizations. While brain stimulation techniques show promise in reducing tic severity, optimal target networks are not well-defined. Here, we leverage datasets from two independent deep brain stimulation (DBS) cohorts and a cohort of tic-inducing lesions to infer critical networks for treatment and occurrence of tics by mapping stimulation sites and lesions to a functional connectome derived from 1,000 healthy participants. We find that greater tic reduction is linked to higher connectivity of DBS sites (N = 37) with action-related functional resting-state networks, i.e., the cingulo-opercular (r = 0.62; p < 0.001) and somato-cognitive action networks (r = 0.47; p = 0.002). Regions of the cingulo-opercular network best match the optimal connectivity profiles of thalamic DBS. We replicate the significance of targeting cingulo-opercular and somato-cognitive action network connectivity in an independent DBS cohort (N = 10). Finally, we demonstrate that tic-inducing brain lesions (N = 22) exhibit similar connectivity to these networks. Collectively, these results suggest a critical role for these action-related networks in the pathophysiology and treatment of GTS.

21 October 2023 in Sensors
Verified
Journal Article
Open access
PDF file
CLChristina van der Linden
Christina van der Linden
TBThea Berger
Thea Berger
GBGregor A. Brandt
Gregor A. Brandt
JSJoshua Niklas Strelow
Joshua Niklas Strelow
HJHannah Jergas
Hannah Jergas
Till A. DembekTill A. Dembek
Till A. Dembek
Clinical rating scales for tremors have significant limitations due to low resolution, high rater dependency, and lack of applicability in outpatient settings. Reliable, quantitative approaches for assessing tremor severity are warranted, especially evaluating treatment effects, e.g., of deep brain stimulation (DBS). We aimed to investigate how different accelerometry metrics can objectively classify tremor amplitude of Essential Tremor (ET) and tremor in Parkinson’s Disease (PD). We assessed 860 resting and postural tremor trials in 16 patients with ET and 25 patients with PD under different DBS settings. Clinical ratings were compared to different metrics, based on either spectral components in the tremorband or pure acceleration, derived from simultaneous triaxial accelerometry captured at the index finger and wrist. Nonlinear regression was applied to a training dataset to determine the relationship between accelerometry and clinical ratings, which was then evaluated in a holdout dataset. All of the investigated accelerometry metrics could predict clinical tremor ratings with a high concordance (>70%) and substantial interrater reliability (Cohen’s weighted Kappa > 0.7) in out-of-sample data. Finger-worn accelerometry performed slightly better than wrist-worn accelerometry. We conclude that triaxial accelerometry reliably quantifies resting and postural tremor amplitude in ET and PD patients. A full release of our dataset and software allows for implementation, development, training, and validation of novel methods.

23 February 2026 in Brain Stimulation
Verified
Journal Article
Open access
CLChristina van der Linden
Christina van der Linden
TBThea Berger
Thea Berger
TDTill A. Dembek
Till A. Dembek
GBGregor A. Brandt
Gregor A. Brandt
JSJoshua N. Strelow
Joshua N. Strelow
JPJan Niklas Petry-Schmelzer
Jan Niklas Petry-Schmelzer
Imaging-guided programming strategies for deep brain stimulation (DBS) offer the potential to reduce time and complexity. However, evidence-based paradigms tailored to tremor remain unavailable. Converging research points to an involvement of the dentato-rubro-thalamic tract (DRTT) in tremor pathophysiology across diseases, providing a potential target for imaging-guided programming in Essential Tremor (ET) and Parkinson's Disease (PD). To prospectively evaluate whether imaging-guided contact selection for tremor control based on individual tractography of the DRTT is non-inferior to clinical contact selection. Tremor control was assessed in an acute challenge for each DBS contact in 16 ET and 24 PD patients with directional DBS leads in the thalamic ventral intermediate nucleus/ posterior subthalamic area (ET) or subthalamic nucleus (PD). The effect of the clinically most effective contact was compared to the effect of the contact with the largest overlap of the stimulation spread with the individual DRTT. Primary outcome was the difference in relative tremor improvement between clinical and imaging-guided contact selection, assessed by an accelerometry-based tremor score, assuming a non-inferiority margin of ≤ 20%. Tremor control achieved via the imaging-based selected contact was non-inferior to tremor control via the contact chosen by clinical testing for ET (median difference best clinical vs. best imaging-based contact -8%, 95% CI -11.5% to -3.5%) and PD (median difference -10%, 95% CI -20% to -4%). This study provides class-II evidence that the overlap of the stimulation spread with the individual DRTT is a suitable marker for imaging-guided contact selection for DBS in tremor.

29 August 2023 in European Journal of Neurology
Verified
Journal Article
Closed access
CLChristina van der Linden
Christina van der Linden
SDSeda Demir
Seda Demir
HDHaidar Salimi Dafsari
Haidar Salimi Dafsari
GWGilbert Wunderlich
Gilbert Wunderlich
BBBoris Böll
Boris Böll
MRMaria Adele Rueger
Maria Adele Rueger

23 February 2026 in medRxiv
Verified
Preprint
Open access
PDF file
ISIlkem Aysu Sahin
Ilkem Aysu Sahin
KBKonstantin Butenko
Konstantin Butenko
KJKara A. Johnson
Kara A. Johnson
HFHelen Friedrich
Helen Friedrich
SOSimón Oxenford
Simón Oxenford
Andreas HornAndreas Horn
Andreas Horn
Background: Deep brain stimulation has emerged as an effective investigational treatment for select cases of severe Gilles de la Tourette Syndrome. Defining the optimal stimulation sites within different targets and the specific tic improvement network across targets will be important to guide neuromodulation therapies. Methods: This retrospective multi-center cohort study analyzed stimulation locations in patients who received bilateral deep brain stimulation for Gilles de la Tourette Syndrome across 12 centers world-wide. The brain targets included the thalamus (n=43), pallidum (n=56) and subthalamic nucleus (n=16). The median follow-up period was 6 months. Imaging data were processed using a dedicated pipeline and a recently introduced voxel-wise sweetspot mapping technique. Since tic response landscapes visually resembled streamline tract connections, we carried out extensive anatomical delineations of pallidothalamic and thalamostriatal fibers. This anatomical information was used to interpret sweetspot landscapes across the three target regions. Results: Tic response maps revealed three tic-response peaks in both thalamus and pallidum. Based on thalamic and pallidal response maps, outcomes in the subthalamic DBS cohort, stimulated between the two other targets, could be explained (R=0.58, p=0.019). Across the three targets, response maps followed the anatomical course of three bundles. Namely, specific subregions of the ansa lenticularis, the fasciculus lenticularis, and projections from the posterior intralaminar thalamic nuclei to the lentiform nucleus. Stimulation overlaps with these bundles explained 19% of the variance in tic improvement across the three targets. Response maps could explain variance in an independent test cohort (n=8, R=0.70, p=0.026). Response maps were also calculated for obsessive compulsive behavior, which revealed similarities to the tic response sites in pallidum but clearly distinct results and generally less efficacy in the thalamus. Conclusion: Our analyses identified tic response targets that followed the course of known structural projections interconnecting pallidum and thalamus.

24 December 2025 in Trials
Verified
Journal Article
Open access
PDF file
POPaulina M. Olgemöller
Paulina M. Olgemöller
EKElke Kalbe
Elke Kalbe
CLChristina van der Linden
Christina van der Linden
MBMichael T. Barbe
Michael T. Barbe
MHMartin Hellmich
Martin Hellmich
AFAnn-Kristin Folkerts
Ann-Kristin Folkerts
Background: Cognitive impairment is common in Parkinson’s disease (PD). Up to 80% of people with PD develop dementia over the disease course, heavily impacting their quality of life. While pharmacological treatment options are scarce, previous research highlights the potential benefits of non-pharmacological interventions, such as cognitive training (CT), on cognition and non-cognitive outcomes. This study’s purpose is to examine the feasibility as well as short- and long-term effects of a 5-week digital CT in people with advanced PD, compared to people with advanced PD receiving care as usual, and to explore possible predictors of CT responsiveness. Methods: This ongoing monocentric, two-armed randomized controlled trial (RCT) seeks to include 140 participants with advanced PD according to the established 5-2-1 criteria. Participants are randomized into either the experimental group, receiving a structured 5-week digital CT and additional psychoeducational videos on cognitive health, or a passive control group receiving care as usual. CT will be carried out remotely from home and supervised by the study team. Feasibility will be assessed using a training diary (e.g., motivation, satisfaction) and technical data (e.g., training duration). Neuropsychological assessments will be carried out pre- and post-CT and after a 3-month follow-up period. The primary outcome will be global cognition measured with the Montréal Cognitive Assessment (MoCA). Secondary outcomes include further cognitive, motor, and (neuro)psychological variables (e.g., quality of life, motor symptoms, mood, activities of daily living). Discussion: Studies on CT in people with PD have demonstrated positive effects on cognition, promoting the application of CT as a non-pharmacological treatment approach. However, studies targeting people in more advanced PD stages are rare or non-existent, despite it being a clinically relevant target group. Further, few studies have looked at long-term CT effects in PD, and very little data exists regarding CT predictors. Therefore, this large-cohort study of a multi-domain digital CT in people with advanced PD aims to provide insights into the effects, feasibility, and acceptability of CT within a representative sample of people with PD, allowing for statistically high-powered analyses and the identification of potential CT predictors. Trial registration: German Clinical Trials Register (DRKS) DRKS00028876. Registered on 21 November 2022